This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Frye, S. et al. US academic drug discovery. Nature Rev. Drug Discov. 10, 409–410 (2011).
Rathi, A. Removing boundaries. RSC News 10–11 (Jan 2013).
Acknowledgements
The authors thank the survey participants and acknowledge the help received from Thomson Reuters Life Sciences to run and analyse the survey, and in supplying comparative industry data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.T.-S. and C.L. act as consultants to academia, biotechnology companies and pharmaceutical companies.
Supplementary information
Supplementary information S1 (box)
Academic Drug Discovery Study (PDF 742 kb)
Supplementary information S2 (box)
Survey methods and supplementary data (PDF 2798 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Tralau-Stewart, C., Low, C. & Marlin, N. UK academic drug discovery. Nat Rev Drug Discov 13, 15–16 (2014). https://doi.org/10.1038/nrd4200
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4200
This article is cited by
-
Academic drug discovery within the United Kingdom: a reassessment
Nature Reviews Drug Discovery (2015)
-
Reply to: “Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives” Inflammopharmacology DOI:10.1007/s10787-014-0202-3
Inflammopharmacology (2015)